Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia

@inproceedings{Gonzaga2017MesenchymalSC,
  title={Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia},
  author={Vivian Fonseca Gonzaga and Cristiane Valverde Wenceslau and Gustavo Sabino Lisboa and Eduardo Os{\'o}rio Frare and Irina Kerkis},
  booktitle={Stem cells international},
  year={2017}
}
Acquired aplastic anemia (AA) is a type of bone marrow failure (BMF) syndrome characterized by partial or total bone marrow (BM) destruction resulting in peripheral blood (PB) pancytopenia, which is the reduction in the number of red blood cells (RBC) and white blood cells (WBC), as well as platelets (PLT). The first-line treatment option of AA is given by hematopoietic stem cell (HSCs) transplant and/or immunosuppressive (IS) drug administration. Some patients did not respond to the treatment… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
1 Extracted Citations
134 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 134 references

Similar Papers

Loading similar papers…